kaiser semaglutide criteria Population‐level impact of 2.4 mg in patients with obesity or overweight and cardiovascular disease: A modelling study based on the SELECT trial - Nanna - 2025 - Diabetes, Obesity and Metabolism Does Kaiser Permanente Cover Semaglutide

Unlike PDE-5 inhibitors, it acts directly on the central nervous system via melanocortin pathways

At the maximum maintenance dose of 2.4mg per week, that same vial drops to roughly 4 doses

I highly recommend it

Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis

Personalized Nutrition and Genetic Insights on PlexusDx The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways

They have (slightly) different FDA approvals